Additionally, IL-6 is associated with aggressive prostate cancer phenotype and may be involved in the metastatic process through regulation of the epithelial–mesenchymal transition (EMT) and homing of cancer cells to the bone [84]. This evidence concerns the gene IL6 and prostate carcinoma.